Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 64 out of 100. Biomarkers

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

This study proposes a model that relates disease stages to Alzheimer's disease biomarkers. It suggests that beta-amyloid biomarkers become abnormal first while individuals remain cognitively normal. Subsequently, neurodegenerative biomarkers become abnormal later and correlate with clinical symptom severity.

What this study adds

Evidence grade: Low

Proposes a model of how biomarkers of the Alzheimer's pathological cascade change over the course of the disease. The authors label the model hypothetical, so it offers a framework for ordering biomarker measurements rather than a tested treatment.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S. S., Weiner, M. W., et al. (2009). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(09)70299-6

Vancouver

Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PSS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. The Lancet Neurology. 2009. doi:10.1016/s1474-4422(09)70299-6. PMID: 20083042.

BibTeX

@article{jack2009-20083042,
  author  = {Jack, Clifford R. and Knopman, David S. and Jagust, William J. and Shaw, Leslie M. and Aisen, Paul S. S. and Weiner, Michael Walter and Petersen, Ronald Carl and Trojanowski, John Q.},
  title   = {{Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade}},
  journal = {The Lancet Neurology},
  year    = {2009},
  doi     = {10.1016/s1474-4422(09)70299-6},
  pmid    = {20083042},
  url     = {https://doi.org/10.1016/s1474-4422(09)70299-6}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Why it matters

Proposes a model of how biomarkers of the Alzheimer's pathological cascade change over the course of the disease. The authors label the model hypothetical, so it offers a framework for ordering biomarker measurements rather than a tested treatment.

Study details

How this study scored 64/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 7 of 7; Citations per year 5 of 5; Impact for its field and year 6 of 6; Cited by studies here 6 of 6; Still being cited 4 of 4; Senior author's track record 4 of 4; Institution's track record 2 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 64 of 100.64 of 100 points earned36 not earned

Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (The Lancet Neurology)
Journal's citation record 3 / 4 The Lancet Neurology: journal h-index 457 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2009 — within 20 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 7 / 7 Cited 4,798 times (OpenAlex, 2026-10-10)
Citations per year 5 / 5 252.5 citations a year over 19 year(s) since 2009
Impact for its field and year 6 / 6 Cited 114.8× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 6 / 6 Cited by 335 other studies in this library
Still being cited 4 / 4 Cited 851 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author John Q. Trojanowski: h-index 255 (OpenAlex, whole career)
Institution's track record 2 / 3 University of California, Berkeley: institution h-index 2,012 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 5 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 20083042)
Free to read 2 / 2 Free to read
Total 64 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 57.

Later studies that cite this one

335 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Biomarkers from nearby years

Also tagged “cerebrospinal”

820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Biomarkers

See all studies in Biomarkers →